Could some GI cancer patients avoid major surgery? new study explores organ preservation
NCT ID NCT07642323
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether people with certain genetic types of gastrointestinal cancers (stomach, colorectal, or anal) can safely avoid major surgery after immunotherapy. Instead of removing the organ, doctors will monitor closely or do smaller procedures to remove any remaining cancer. The goal is to see if this gentler approach works as well as surgery and helps patients have a better quality of life. About 22 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New platform aims to personalize cancer treatment for GI patients
- Could silkworm pupas be the key to fighting muscle loss in cancer survivors?
- New hope for stomach and bowel cancers: experimental drug Rina-S enters Mid-Stage trial
- New hope for stomach cancer: experimental drug BHB810 enters human trials
- Tailored training may boost healthy living in GI cancer survivors
- New scanner could sharpen cancer radiation treatment